173341-02-1

Basic information

• Product Name: 2-N-BOC-AMINOMETHYLMORPHOLINE
• Synonyms: 2-N-BOC-AMINOMETHYLMORPHOLINE ;tert-butyl (morpholin-2-ylmethyl)carbamate;tert-butyl (morpholin-2-ylmethyl)carbamate(SALTDATA: FREE);Carbamic acid,N-(2-morpholinylmethyl)-, 1,1-dimethylethyl ester;tert-butyl N-(morpholin-2-ylmethyl)carbamate
• CAS NO: 173341-02-1
• Molecular Formula: C₁₀H₂₀N₂O₃
• Molecular Weight: 216.2774
• Mol File: 173341-02-1.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 334 °C at 760 mmHg
• Flash Point: 155.8 °C
• Appearance: /
• Density: 1.032 g/cm³
• Vapor Pressure: 0.000131mmHg at 25°C
• Refractive Index: 1.452
• Storage Temp.: 2-8°C(protect from light)
• PKA: 12.22±0.46(Predicted)
• CAS DataBase Reference: 2-N-BOC-AMINOMETHYLMORPHOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-N-BOC-AMINOMETHYLMORPHOLINE(173341-02-1)
• EPA Substance Registry System: 2-N-BOC-AMINOMETHYLMORPHOLINE(173341-02-1)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 173341-02-1(Hazardous Substances Data)

Usage

General Description

"2-N-BOC-Aminomethylmorpholine" is a chemical compound used as a reactant or raw material in a diverse array of industrial and scientific processes. Its chemical formula is C10H20N2O3, and it features a morpholine ring, making it a member of the morpholine chemical family. The "BOC" in its name refers to the presence of a tert-butoxycarbonyl protecting group, which is often used in chemistry to prevent unwanted reactions. Due to its structure and the presence of an amine group, this chemical is often utilized in pharmaceutical development and in the synthesis of other complex organic compounds. It is typically stored under inert gas due to its sensitive reactions with other substances.

InChI:InChI=1/C10H20N2O3/c1-10(2,3)15-9(13)12-7-8-6-11-4-5-14-8/h8,11H,4-7H2,1-3H3,(H,12,13)

Upstream product

• 146944-34-5 (4-benzylmorpholin-2-ylmethyl)carbamic acid tert-butyl ester 
• 112913-97-0 2-(azidomethyl)-4-benzylmorpholine 
• 40987-25-5 N-benzyl-2-chloromethylmorpholine 
• 110859-47-7 (4-benzylmorpholin-2-yl)methanamine 

Downstream Products

• 558465-42-2 t-butyl {[4-[5-chloro-4-[(4-chlorophenylthio)(2,5-difluorophenyl)methyl]pyridine-2-yl]morpholine-2-yl]methyl}carbamate 
• 1034769-89-5 tert-butyl (4-(5-bromo-1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl)methylcarbamate 
• 1034769-80-6 tert-butyl (4-(2-(benzylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)morpholin-2-yl)methylcarbamate 
• 1034769-97-5 tert-butyl (4-(1-(4-methoxybenzyl)-5-(3-methyl-1,2,4-oxadiazol-5-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl)methylcarbamate 
• 1351533-45-3 tert‐butyl ((4‐(5‐(3‐cyanophenyl)‐7H‐pyrrolo[2,3‐d]pyrimidin‐4‐yl)morpholin‐2‐yl)methyl)carbamate 
• 1610505-80-0 [4-(4-trifluoromethylphenyl)morpholin-2-ylmethyl]carbamic acid tert-butyl ester 
• 1427588-42-8 3-cyclopropyl-1-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)urea 
• 1427588-41-7 propan-2-yl N-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1427589-25-0 tert-butyl N-({4-[1-(4-chlorophenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1334713-60-8 tert-butyl N-({4-[1-(4-methylphenyl)-1H-pyrazolo[3,4-c]pyridin-3-yl]morpholin-2-yl}methyl)carbamate 
• 1185190-89-9 tert-butyl {4-[4-(3,5-dimethyl-phenylsulfanyl)-5-iodo-2-methyl-6-oxo-1,6-dihydropyridin-3-ylmethyl]-morpholin-2-ylmethyl}-carbamate 

Relevant articles and documents

INDAZOLE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

The present invention relates to novel indazole compounds of the Formula (I), wherein, R1 is alkyl or cycloalkyl; (Formula II) including their stereoisomers and their pharmaceutically acceptable salts. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to 5-Hydroxytryptamine 4 (5-HT4) receptor agonists

ANTIBACTERIAL AGENTS

Naphthalene, quinoline, quinoxaline and naphthyridine derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein.

NOVEL COMPOUNDS WITH ANTIBACTERIAL ACTIVITY

The invention relates to novel antibacterial compounds of formula (I).